# Summary of Work

## Deliverable
`output/compromise-proposals.docx` — a privileged, negotiation-ready memorandum drafting compromise clause language and rationale for the seven contested terms in the Meridian Health Systems / Cognitive Foundry ClinIQ™ Platform Master AI Services Agreement.

## Process
I reviewed all 12 source documents in the workspace:
- **Contested Terms Matrix** (the seven terms, both parties' positions, red lines, financial figures)
- **Delgado internal memo** (priority framework, comparable-deal intelligence, CFO intelligence on graduated ETF, data-usage-as-concession-currency strategy)
- **Sutter instruction email** (four-component proposal format, Dr. Narayanan's absolute red lines, vendor flexibility intelligence, work allocation)
- **Meridian Negotiation Playbook** (fallback ladders, absolute floors, board-approved risk tolerances, approved clause bank)
- **NJ AI Healthcare Transparency Act summary** (statutory audit mandate, anti-waiver provision, $50K/violation penalties, vendor-contracting requirements)
- **Cognitive Foundry contract standards summary** (vendor's standard positions: 1× cap, IP-only indemnity, no uncapped liability, 90-day opt-out)
- **Langford audit scope proposal** (Tier 1/2/3 access framework, secure-enclave protocol, confidentiality protections)
- **Customer redline & vendor response redline** of the master agreement (actual clause evolution, June 20 → June 30 positions)
- **Exhibit C (SLA) & Exhibit D (Data Governance)** (benchmark details, credit structures, bracketed alternatives)

## Document Structure
The deliverable contains, for each of the seven contested terms (in Meridian's priority order):
- **(A)** Recommended compromise position
- **(B)** Redline-ready proposed clause language
- **(C)** Negotiation rationale and fallback ladder (mapping both parties' positions and red lines)
- **(D)** Acceptability analysis for the Vendor team (anticipating Sandra Hu's commercial-flexibility objections and Rafael Bowen's liability/IP objections)
- **(E)** Regulatory and compliance constraints (HIPAA, NJ AI Act, FDA guidance)

Plus front matter (deal context, priority framework, concession strategy, summary table) and closing sections (cross-cutting insurance issue, coordinated liability-package logic, Board Risk Committee considerations, and July 18 session sequencing strategy).

## Concession Calibration
Concessions were calibrated to Meridian's board-approved priority ranking and strategic guidance:
- **Priority 1 (patient-safety):** Held the 3× ACV floor absolutely; accepted 1.5× general cap (vendor's counter = Meridian's floor) in exchange for bringing patient-safety + HIPAA inside the 3× super-cap.
- **Priority 2 (audit):** Landed at Playbook second fallback (annual Langford Tier 2 + Tier 3 secure-enclave for cause), backed by the NJ Act's statutory mandate.
- **Priority 3 (termination):** Accepted a graduated ETF (50/25/0/0) per CFO intelligence, paired with cost+5% transition, no ARF during transition, and FHIR R4/HL7 v2 data export.
- **Priority 4 (data usage):** Designed as concession currency — controlled-use framework (model improvement + benchmarking only) deployed last in exchange for movement on Terms 1–3.
- **Priority 5 (SLA):** Held binding status (red line); conceded 3-miss termination trigger (vs. 2).
- **Priority 6 (IP):** Accepted Playbook final fallback (vendor ownership + irrevocable perpetual license + deployable-artifact portability), avoiding the CTO's "hard no."
- **Priority 7 (indemnification):** Accepted shared defense (vendor primary for AI-output claims) + super-capped, in exchange for broadened scope (IP + data breach + NJ Act regulatory + patient-harm).

The .docx was generated via Pandoc and validated with the docx skill's `validate.py` (exit 0).